AUPH

Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH)

About Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH)

Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Details

Daily high

$9.23

Daily low

$8.92

Price at open

$8.95

52 Week High

$10.67

52 Week Low

$4.71

Market cap

1.3B

Dividend yield

0.00%

Volume

1.6M

Avg. volume

1.5M

P/E ratio

-57.15

Aurinia Pharmaceuticals Inc Ordinary Shares News